EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, Bioevaluation, and Bioinformatics Study of 5‐Benzylidene Hydantoin Derivatives as Novel Tyrosine Kinase Inhibitors

Muhammad Naufal iD, Elvira Hermawati iD, Ade Danova iD, Ika Wiani Hidayat, Jamaludin Al-Anshori iD

ChemistryOpen · 2026-01 · 15 (1)

DOI: 10.1002/open.202500158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistryOpen, online erschienen am 09.10.2025. Verfasst von Muhammad Naufal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang km.21, Jatinangor, 45363, In…. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Hydantoins, Drug Design, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kemendikbud-Ristek, PDD, PFR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tyrosine kinases regulate cellular growth, differentiation, and metabolism, and their dysregulation is implicated in malignancies, making them therapeutic targets. This study synthesizes novel 5‐benzylidene hydantoin derivatives (24–38) via benzylation and condensation, characterized by nuclear magnetic resonance (NMR), mass spectrometry, and fourier‐transform infrared (FTIR). Anticancer activity was evaluated against eight receptor tyrosine kinases at 10 μM. Six compounds—24 (34%), 25 (45%), 28 (57%), 32 (60%), 34 (49%), and 38 (56%)—show moderate HER2 inhibition (%enzyme activity ≤ 60%). Compound 38 additionally inhibits VEGFR2 (27%), PDGFRα (32%), and PDGFRβ (25%). Molecular docking reveals interactions with HER2 residues Met801, Leu726, Leu852, Phe1004, Val734, and Leu796, suggesting a structural basis for selectivity. The HER2‐targeting derivatives demonstrate potential for development as novel HER2 inhibitors. Compound 38's multikinase inhibition resembles sunitinib, a clinically approved drug for renal cell carcinoma and gastrointestinal stromal tumors, highlighting its promise for broader kinase‐targeted therapy. These findings underscore the therapeutic relevance of the 5‐benzylidene hydantoin scaffold, warranting further optimization to enhance potency and selectivity against HER2 and other oncogenic kinases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsHydantoinsDrug DesignAntineoplastic AgentsHumansMolecular Docking SimulationComputational BiologyStructure-Activity RelationshipCell Line, TumorCell ProliferationVascular Endothelial Growth Factor Receptor-2Erb-b2 Receptor Tyrosine KinasesTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

cancerheterocyclichydantointyrosine kinase

Substanzen

Protein Kinase InhibitorsHydantoinsAntineoplastic AgentsVascular Endothelial Growth Factor Receptor-2Erb-b2 Receptor Tyrosine KinasesTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang km.21, Jatinangor, 45363, Indonesia.
  • Division of Organic Chemistry, Faculty of Mathematics and Natural Sciences, Institut Teknologi Bandung, Jl. Ganesha 10, Bandung, 40132, Indonesia.

ORCID-Profile: Muhammad Naufal, Elvira Hermawati, Ade Danova, Jamaludin Al-Anshori

Förderung

  • Kemendikbud-Ristek
  • PDD
  • PFR

Zitieren

APA

Naufal, M., Hermawati, E., Danova, A., Hidayat, I. W., & Al-Anshori, J. (2026). Design, Synthesis, Bioevaluation, and Bioinformatics Study of 5‐Benzylidene Hydantoin Derivatives as Novel Tyrosine Kinase Inhibitors. ChemistryOpen, 15(1). https://doi.org/10.1002/open.202500158

Vancouver

Naufal M, Hermawati E, Danova A, Hidayat IW, Al-Anshori J. Design, Synthesis, Bioevaluation, and Bioinformatics Study of 5‐Benzylidene Hydantoin Derivatives as Novel Tyrosine Kinase Inhibitors. ChemistryOpen. 2026;15(1). doi:10.1002/open.202500158

BibTeX
@article{Naufal2026,
  author = {Naufal, Muhammad and Hermawati, Elvira and Danova, Ade and Hidayat, Ika Wiani and Al-Anshori, Jamaludin},
  title = {Design, Synthesis, Bioevaluation, and Bioinformatics Study of 5‐Benzylidene Hydantoin Derivatives as Novel Tyrosine Kinase Inhibitors},
  journal = {ChemistryOpen},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1002/open.202500158}
}
Kostenlos starten →